{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:11:17Z","timestamp":1648509077619},"reference-count":11,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1272\/jnms.80.155","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T03:12:32Z","timestamp":1367982752000},"page":"155-159","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Eculizumab in a Patient with Paroxysmal Nocturnal Hemoglobinuria Requiring Transfusions 14 Years after a Diagnosis in Childhood"],"prefix":"10.1272","volume":"80","author":[{"given":"Takahiro","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Yamanishi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Parker C, Omine M, Richards S, et al.: Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005; 106: 3699-3709.","DOI":"10.1182\/blood-2005-04-1717"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333: 1253-1258.","DOI":"10.1056\/NEJM199511093331904"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hill A, Richards SJ, Hillmen P: Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Br J Haematol 2007; 137: 181-192.","DOI":"10.1111\/j.1365-2141.2007.06554.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Meyers G, Weitz I, Lamy T, et al.: Disease-related symptoms reported across a broad population of patients with paroxysmal nocturnal hemoglobinuria. Blood 2007; 110 abstract 3683.","DOI":"10.1182\/blood.V110.11.3683.3683"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hillmen P, Young NS, Schubert J, et al.: The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006; 355: 1233-1243.","DOI":"10.1056\/NEJMoa061648"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE: Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002; 24: 547-561.","DOI":"10.1016\/S0885-3924(02)00529-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schubert J, Hillmen P, Roth A, et al.: Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 2008; 142: 263-272.","DOI":"10.1111\/j.1365-2141.2008.07183.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Roth A, Duhrsen U: Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Eur J Haematol 2011; 87: 473-479.","DOI":"10.1111\/j.1600-0609.2011.01701.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Risitano AM, Notaro R, Marando L, et al.: Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood 2009; 113: 4094-4100.","DOI":"10.1182\/blood-2008-11-189944"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hill A, Rother RP, Arnold L, et al.: Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization. Haematologica 2010; 95: 567-573.","DOI":"10.3324\/haematol.2009.007229"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kelly RJ, Hill A, Arnold LM, et al.: Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 2011; 117: 6786-6792.","DOI":"10.1182\/blood-2011-02-333997"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/80\/2\/80_155\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T07:44:24Z","timestamp":1617003864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/80\/2\/80_155\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.80.155","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}